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ABSTRACT 
 
 
 
Testing the Rationale of Candida Cleanse Diets 
Sallie Katherine Lewis, B.S.  
Department of Biology 
Western Carolina University (July 2014) 
Director:  Dr. Greg Adkison 
 Some practitioners of alternative medicine identify overgrowth of the fungus 
Candida as the cause of eczema, psoriasis, and conditions like fibromyalgia, depression, 
and chronic migraines.  These naturopathic physicians may prescribe diets low in 
carbohydrates (Candida cleanse diets) to treat such conditions.  This study examined the 
rationale of this diagnosis and treatment by testing for a relationship between the amount 
of carbohydrates people consume and the presence of Candida in their mouths.  It is 
possible that nutrients other than carbohydrates also affect the growth of Candida.  
Therefore this study also tested for an association between the oral presence of Candida 
and the amounts of refined sugars, protein, fat, saturated fat, vitamin A, vitamin C, iron, 
and calcium consumed.  Participants recorded the amounts of food and drink they 
consumed for three weeks.  Daily average amount of each nutrient consumed was 
calculated for each participant each week.  Participants sampled their mouths at the end 
of each week and inoculated CHROMagar plates (BD Diagnosis Systems) with the 
samples.  The inoculated plates were incubated at 37ºC for three days and then examined 
for Candida growth.  The probability of Candida growth was negatively related to 
consumption of carbohydrate, protein, total fat, and saturated fat during week 1.  No other 
 
statistically significant associations were detected.  These results refute the rationale 
behind Candida cleanse diets. 
1 
INTRODUCTION 
 
 
 
 Candida Hypersensitivity Syndrome (CHS) describes a variety of 
ailments/symptoms associated with Candida overgrowth (Crook 1983).  According to 
Barrett (2005), advocates of CHS believe overgrowth of Candida can lead to hyphal 
penetration of protective mucosal linings of the gastrointestinal, oral, and vaginal cavities 
enabling a variety of foreign toxins and allergens to enter the blood stream where they 
can overwhelm the immune system (Truss 1981, Crook 1983, Murray 1997).  Some 
practitioners of alternative medicine blame the overgrowth of C. albicans for superficial 
infections like vaginitis and oral thrush as well as systemic conditions such as 
fibromyalgia, depression, autism, and chronic migraine (Fasano 2003, Fife 2005, Edelson 
2007).  Candida survives by metabolizing sugars.  This often prompts holistic physicians 
to prescribe diets low in or even absent of carbohydrates.  These diets are known as 
Candida cleanse diets (CCD). Proponents of CCD reason that the many conditions they 
attribute to CHS can be relieved if Candida is reduced (Barrett 2005).  They claim this 
dietary regimen is an effective treatment against the conditions linked to candidiasis and 
CHS. 
 The ever-increasing clinical threat presented by the growing 
immunocompromised population has brought Candida infections to the forefront of 
medical concern because they often lead to lengthened hospital stays and inflated medical 
costs (Barrett 2005).  The growth of this high-risk group has been caused by a variety of 
factors including the continued spread of Human Immunodeficiency Virus (HIV) (Crowe 
et al. 1994, Cheng et al. 2005).  As of 2010, an estimated 34 million people worldwide 
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were living with HIV/AIDS, a dramatic rise over the eight million documented cases in 
1990 (Worldwide HIV and AIDS Statistics 2011). Overuse of antibiotics has also 
contributed to the increasing number of Candida infections (Wang et al. 2014).  This is 
because along with eliminating harmful bacteria antibiotics often alter the balance of 
beneficial bacteria responsible for keeping Candida in check, particularly in the 
gastrointestinal tract and genitals.  Members of the genera Lactobacillus and 
Bifidobacterium, many of which are widely used as probiotics, are most commonly 
associated with maintaining gastrointestinal conditions for proper nutrition (Lidbeck and 
Nord 1993, Isolauri et al. 2002, Isolauri et al. 2004).  Immune compromising drugs are 
also blamed for increased cases of Candida infections (Louria et al. 1960, Singh 2001).  
These drugs include corticosteroids (commonly given to treat inflammation), 
antirejection medications (administered to organ transplant recipients), immuno-
suppressants (used to treat autoimmune disorders such as systemic lupus erythematosus 
and Chrohn’s disease), and a variety of chemotherapeutics used to fight many cancers. 
 Most members of genus Candida are ubiquitous, having been cultured from soil 
and water. The most relevant clinical species, C. albicans, prefers conditions found in the 
human body (Blaschke-Hellmessen 1999, Shin 2001, Yamaguchi et al. 2007). This is 
primarily due to its affinity to grow at body temperature in a moist environment (Sullivan 
et al. 1983, Blaschke-Hellmessen 1999).  Candida species are the most frequently 
recovered fungal pathogens that are isolated from clinical samples worldwide, and they 
are responsible for an estimated 10,000 deaths annually in the United States alone 
(Musial et al. 1988, Sudbery et al. 2004).  Of the over 150 known species, fewer than 20 
are pathogenic, the most common of these being C. albicans, followed by C. glabrata, C. 
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tropicalis, C. parapsilosis, and C. krusei (Pfaller et al. 2005, Lim et al. 2012).  Although 
the incidence of infection by species other than C. albicans has dramatically risen over 
the past decade, C. albicans is still responsible for 50-66% of candidiasis cases (Sudbery 
et al. 2004, Lim et al. 2012). 
 The prevalence of C. albicans may be a result of its unique virulence factors with 
the most significant being its ability to morphologically switch between yeast and hyphal 
form (Sudbery et al. 2004).  Candida exists in yeast form as single round or ovoid cells, a 
morphology well suited for dispersal. After dispersing through a person’s body, the 
fungus is able to switch to a filamentous form that allows it to penetrate protective 
mucosal linings and invade the tissues below leading to infection of organs (Sudbery et 
al. 2004).  Such filaments may form as true hyphae or pseudohyphae. Other than the 
more recently classified C. dublineinsis, C. albicans is the only Candida species able to 
form true hyphae as opposed to just pseudohyphae (Ells et al. 2009).  Constricted septa 
differentiate true hyphae from pseudohyphae (Sudbury et al. 2004).  The change from 
yeast to filamentous form can be triggered by a variety of factors including an increase in 
temperature, lack of nutrients, a change in pH, and a reduction in O2 levels (Uwamahor 
and Traven 2010). 
 Hazan et al. (2002) demonstrated that hyphae specific genes are activated under 
conditions typically found in the human body (i.e., 37ºC and pH ≈ 7).  Among the 
activated hyphae specific genes are ALS3 and ALS8, which encode for the production of 
adhesins.  Adhesins allow C. albicans to stick to human cells and form biofilms (Ramage 
et al. 2005).  The ability of Candida to form biofilms makes it particularly dangerous to 
people using catheters and respirators, a characteristic accounting for the dramatic 
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increase of nosocomially acquired C. albicans infection (Pfaller 1996, Wisplinghoff et al. 
2004, Wenzel and Gennings 2005).  In fact, C. albicans is the fourth leading cause of 
hospital acquired bloodstream infections (Pfaller 1996, Wisplinghoff et al. 2004). 
 Traditionally, Candida related illnesses and infections have been managed by a 
class of drugs collectively known as antifungals.  Candida infections are often 
challenging to treat because of their persistent nature.  Just as antibiotics act by targeting 
the differences between mammalian and bacterial cells, antifungals act by exploiting the 
differences between mammalian and fungal cells.  Antifungal design has been 
significantly more challenging than the design of antibiotics because fungi, like 
mammals, are composed of eukaryotic cells (Dixon and Walsh 1996).  Host-pathogen 
similarity is primarily responsible for many of the adverse side effects brought on by the 
administration of traditional antifungals.  The most common adverse reactions are renal 
toxicity, altered estrogen production, and several fatal drug interactions (Dixon and Walsh 
1996, Dismukes 2000). 
 To date there are four main classes of antifungals each with their own distinct 
structure and mechanism of action: the azoles, the polyenes, the allylamines, and the 
echinocandins (Long 2003).  The largest of these classes are the azoles, a group of 5-
membered heterocyclic, nitrogen-containing compounds that act by inhibiting a fungal 
cytochrome P450 enzyme known as 14-α demethylase (MacCallum et al. 2010).  The 
P450 protein is coded for by a gene superfamily known as CYR.  The cytochrome P450 
superfamily is primarily composed of enzymes able to catalyze the oxidation of organic 
molecules (Guengerich 1995, Bernhardt 2006).  In the case of azoles, 14-α demethylase 
prevents the demethylation of lanosterol, a precursor of egrosterol, a necessary 
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component of fungal cell membranes (Andriole 1999).  The azoles, polyenes, and 
allylamines all share a similar mode of action interrupting the synthesis of fungal cell 
membranes.  Their activity is based on the inhibition of different enzymes required for 
the synthesis of egrosterol, a fundamental component of fungal cell membranes (Ryder 
1987, Dixon and Walsh 1996, Hospenthal and Rinaldi 2008, MacCallum et al. 2010).  
This general mechanism of action prevents proper fungal cell membrane formation, 
thereby inhibiting Candida cell proliferation. Although effective, these drugs have been 
associated with dangerous side effects including many drug interactions as well as renal 
and hepatic toxicity (Ashley et al. 2006).  In contrast, some drugs belonging to these 
classes such as Monistat, Gyne-Lotrimin, Lamisil, and Lotrimin Ultra are available over 
the counter. Butenafine, the most commonly used allylamine, is distinguished from other 
members of its class by superior activity against C. albicans (Ryder 1987).  The 
increasing incidence of resistance to these antifungals suggests alternative treatments are 
needed (Pfaller 2012). 
 Unlike the previously mentioned drugs, echinocandins possess a novel 
mechanism of action and are therefore commonly referred to as the “penicillin of 
antifungals” (Long 2003).  They act by noncompetitively inhibiting 1, 3-β-glucan 
synthase, an enzyme in the cell membrane responsible for producing the glucan polymers 
required for proper cell wall construction (Morris and Villmann 2006).  This damage 
ultimately leads to fungal cell death.  Another distinguishing characteristic of the 
echinocandins is their mode of administration.  They are administered intravenously 
because they are poorly absorbed when taken orally.  Currently approved echinocandins 
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include micafungin, anidulafungin, and caspofungin, the therapy of choice for treating 
systemic Candida infections (Morris and Villmann 2006). 
 
Details of Candida cleanse diets 
 The recent increase in Candida infections has fueled interest in Candida cleanse 
diets (CCD), especially among corporations marketing naturopathic products.  The 
rationale behind CCD is simple.  Sugars are the primary energy source for Candida spp. 
Therefore, removing sugars from a patient’s diet should, in effect, “starve” the invading 
yeast and eventually end the symptoms brought on by its overgrowth (Crook 1983, Truss 
1983, Murray 1997).  There are a number of drawbacks to this approach with the most 
significant being how difficult the strict regimen is to maintain.  Furthermore, there is 
little scientific evidence that it is effective. 
 CCDs stress that patients completely refrain from simple sugars.  Simple sugars 
include both monosaccharides and disaccharides.  Commonly ingested monosaccharides 
include glucose, fructose, and galactose.  They are usually consumed as the disaccharides 
sucrose (glucose–fructose), lactose (glucose–galactose), and maltose (glucose–glucose).  
Although limiting these sugars is beneficial (Martin and Rona 2000), their complete 
restriction is highly impractical, requiring the elimination of breads, many fruits and 
vegetables, and all dairy products.  Mold-containing foods and foods commonly thought 
to cause allergies are also prohibited by CCD (Crook 1983, Murray 1997, Martin and 
Rona 2000).  In addition to refraining from foods containing refined sugar, people 
adhering to CCD must also be wary of white bread, alcohol, mushrooms, squash, yams, 
potatoes, parsnips, corn, peanuts, cashews, dairy products, figs, melons, honey, and 
raisins (Murray 1997).  Length of diets vary, but are typically at least 60 days. 
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 Proponents of CCD also advocate limiting the use of antibiotics, avoiding 
estrogen and progesterone based contraceptives, and consuming commercially available 
probiotics (Murray 1997, Donaldson 2004, Ignacio and Thai 2005).  Less regimented 
plans are available (Alter 2010), however, as with the traditional Candida cleanse diet, 
their efficacy has yet to be demonstrated.  There have been very few reliable experiments 
investigating the clinical value of CCD (Barrett 2005).  Those that have been published 
have provided little real evidence that the Candida cleanse diet offers tangible relief from 
the conditions blamed on CHS (Barrett 2005).  Nevertheless, increasing practice of 
holistic medicine has created renewed interest in CCD. 
 
Nutrition requirements of Candida 
 Like other organisms, C. albicans derives its energy from the breakdown of 
carbohydrates into their simpler constituent sugar molecules.  Refined sugars are purified 
or nearly purified simple sugars (i.e., purified monosaccharides or purified 
disaccharides).  Monosaccharides require no digestion, which means they are absorbed 
almost immediately by Candida or us, depending on which organisms’ absorptive surface 
contacts the sugar first.  Disaccharides require only one chemical bond to be broken 
during digestion, so they too are absorbed almost immediately and easily metabolized. 
For this reason all variations of Candida cleanse diets include complete restriction of 
refined or simple sugars.  Although carbohydrates are the focus of Candida cleanse diets, 
Candida requires other nutrients.  These include protein and fat.  Proteins provide the 
amino acids Canida uses to assemble proteins and nitrogen for other molecules.  Fats 
provide fatty acids for energy and the lipid components Candida uses to build its own 
cell membranes and organelle membranes. 
8 
 Vitamins A and C are both known to contribute to proper immune function and 
have both been shown to decrease growth of C. albicans.  Large doses of vitamin A 
induce nonspecific resistance to C. albicans infection in mice (Cohen and Elin 1974).  
Likewise, vitamin A deficiency contributes to the presence and proliferation of C. 
albicans (McClary 1952).  Vitamin C also discourages C. albicans overgrowth. This 
effect may be caused by vitamin C lowering stomach pH because alkalinity has been 
shown to encourage the hyphal switch responsible for C. albicans pathogenicity (Walther 
and Wendland 2008).  These studies suggest that participants who consumed more 
vitamin A and vitamin C are less likely to test positive for C. albicans. 
 Iron is required for the proliferation of C. albicans, functioning as an obligate 
enzymatic cofactor in a number of biological processes including DNA replication and 
electron transport (Elin and Wilff 1973 and Askwith and Kaplan 1998).  Individuals 
taking iron supplements to treat anemia and related disorders have an increased risk of 
developing Candida infections (Nevitt 2011).  Furthermore, iron depletion makes  the 
cell membranes of Candida more permeable to antifungal drugs (Prasad et al. 2006).  
Calcium plays a critical role in morphogenesis of C. albicans by inhibiting mycelial 
growth (Holmes et al. 1991). Studies suggest that this may be the result of a disruption in 
calcium-dependent directional growth (Brand et al. 2007).  These studies suggest that 
vitamin A, vitamin C, iron, and calcium may also affect C. albicans proliferation. 
 
Study objectives 
 This study examined the rationale of Candida cleanse diets by testing for an 
association between the amount of total carbohydrate, refined sugar, protein, fat, 
saturated fat, vitamin A, vitamin C, iron and calcium in people’s diets and the growth of 
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Candida albicans within the people. A positive association with total carbohydrate or 
refined sugar would indicate that the rationale of Candida cleanse diets is valid, whereas 
a negative association or no association would indicate that the rationale underlying this 
dietary treatment is incorrect. In addition, this study will test for an association between 
the amount of protein, fat, saturated fat, vitamin A, vitamin C, iron and calcium people 
consume and the growth of Candida albicans within them.  Evidence demonstrating the 
efficacy of CCD may provide the medical community with a more effective, less toxic 
option for combating candidiasis, a particularly persistent and widespread condition.  
Additional nutrient associations may provide alternative avenues of treatment. 
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METHODS AND MATERIALS 
 
 
 
Collection of data 
 Participants in the study were volunteers from a biology course at Western 
Carolina University during the 2011 fall semester (Western Carolina University IRB 
2012-021).  Each participant was asked to record what they consumed each day for three 
consecutive weeks. These records included estimated amounts of each item by volume or 
unit (e.g., 1 cup of cereal, ½ cup 2% milk, 1 stick of gum). Participants sampled the 
inside of their mouths with sterile cotton swabs once each week and then inoculated 
“CHROMagar Candida” plates (BD Diagnostic Systems) using aseptic technique. The 
growth medium contained in CHROMagar Candida plates exclusively selects for 
Candida species (e.g., C. albicans, C. glabrata, C. tropicalis, C. krusei) and prevents the 
growth of other organisms (Bouchara et al. 1996, Willinger and Manafi 1999).  After 
sampling the inside of his or her mouth with a sterile cotton swab, each participant 
inoculated a CHROMagar plate using a zig-zag pattern.  Plates were placed into a 37ºC   
incubator within 15 minutes of inoculation. All plates were observed for growth every 24 
hours for three days.  
 Each participant’s plates and corresponding dietary records were identified with a 
randomly assigned number.  The total amount of carbohydrate, refined sugar, protein, fat, 
saturated fat, vitamin A, vitamin C, Fe and Ca consumed each day by each participant 
was determined from the USDA’s “MyPlate” website (choosemyplate.gov) and similar 
nutrition websites (See Appendix 1).  In many cases nutritional data were readily 
available, particularly for food items available at commercial/chain restaurants (e.g. 
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McDonalds, Chik-fil-a, Starbucks, etc.).  In these cases, nutrient quantity consumed was 
calculated by multiplying or dividing the amount of nutrient per serving by the number of 
servings or the fraction of a serving consumed.  Determining the nutritional data for other 
items, specifically food prepared by the participants themselves, required more thorough 
investigation.  This required breaking down certain items into their ingredients, locating 
the nutritional data for each ingredient, and then combining the individual data to 
calculate the items’ total nutrient content.   
 The amount of carbohydrate, refined sugar, protein, total fat, and saturated fat 
contained in a food item was consistently reported, recorded, and analyzed as mass using 
the metric unit milligram.  Nutritional labels and websites reported values for vitamin A, 
vitamin C, Fe, and Ca as the percentage daily value (%DV) of each nutrient.  
Recommended daily allowances (RDA) or daily values (DV) of vitamins and minerals 
are set by the Food and Drug Administration (FDA) and are based on daily 
recommendations for a 2000 calorie per day diet.  A nutrient’s %DV is the percentage of 
that nutrient’s RDA or DV a food or beverage contains.  According to www.fda.gov, the 
RDA of vitamin C, vitamin A, Ca, and Fe is 60 mg, 5000 International Units (IU), 1000 
mg, and 18 mg respectively.  The nutritional supplement database, sponsored by the 
National Institute of Health (NIH), reports 1 IU of vitamin A is equal to approximately 
0.33 µg meaning the %DV for vitamin A is approximately 15mg.  Because vitamin A, 
vitamin C, Fe, and Ca data are consistently reported as %DV this study also recorded and 
analyzed each nutrient using %DV.   
 Each individual’s average daily nutrient intake was determined for weeks 1, 2, 
and 3 then analyzed for its association with Candida growth.  Total carbohydrate, refined 
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sugar, protein, fat, saturated fat, vitamin A, vitamin C, Fe, and Ca intake was summed for 
each combination of individual, week, and day, which yielded each individual’s daily 
total intake of each measured nutrient.  Next the mean of the daily total intake was 
determined generating the average daily total of each measured nutrient for each 
combination of individual and week. 
 
Data analysis 
 Not all of the 116 participants kept dietary records of sufficient quality to be used.  
For example, too little information about ingredients and quantities in some records 
prevented accurate collection of nutritional information.  Thus, sample size differed from 
week to week:  50 during week 1, 46 during week 2, 84 during week 3. 
 The effect of carbohydrate consumption on the presence of Candida was 
examined with logistic regression using the “glm” function in R version 3.0.1 (R Core 
Team 2013).  Logistic regression yielded a measure of how likely the presence of 
Candida is for every 1g increase in carbohydrate consumption.  Specifically, it quantified 
the log odds of Candida being present for every 1g increase in carbohydrate 
consumption.  Odds is related to probability by the following function:  odds = 
probability / (1–probability).  The same approach was used to test for an association 
between presence of Candida and consumption of each measured nutrient, respectively: 
refined sugar, protein, total fat, saturated fat, vitamin A, vitamin C, Fe, and Ca.  The 
“glm” function in R also calculated Wald’s z to determine p-values associated with 
coefficients for each logistic regression.   
 Scatterplots showing observed data (circles) in combination with results of the 
logistic regressions (regression curve and 95% confidence interval) were produced with 
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the “ggplot” package (Wickham 2009) in R version 3.0.1 (R Core Team 2013).  The 
estimated curves and 95% confidence intervals in the scatterplots were produced with R’s 
“glm” smoothing function.  Data from week 1 were examined independently of data from 
week 2 and data from week 3.  Data from week 2 and data from week 3 were also 
examined independently from one another.  This approach, rather than a repeated 
measures design, was taken because participants varied somewhat week to week and 
because each week represented a partly-independent replicate of the survey. 
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RESULTS 
 
 
 
Association between Candida growth and carbohydrate consumption 
 The association between carbohydrate consumption and the presence of Candida 
differed from week to week.  For example, the probability of Candida growth among 
participants declined as carbohydrate consumption increased (b = −0.02) during week 1 
(Figure 1).  Specifically, the result from week one shows that the log odds of Candida 
being present in a person decreases by 0.02 for every 1g increase in carbohydrate 
consumption.  This result is opposite the pattern expected if the rationale of the Candida 
cleanse diet is valid. 
 There was practically no change in the log odds of Candida presence with 
carbohydrate consumption during week 2 among the experiment’s participants (b = 
0.0001, Figure 1).  Week 3’s results indicated a slight increase in the log odds of Candida 
presence with carbohydrate consumption (b = 0.002, Figure 1), but as with the result 
from week 2, the probability of detecting associations of b = 0.0001 (week 2) and b = 
0.002 (week 3) among the experiment’s participants even if the association does not exist 
in the populations represented by the samples is quite large (p = 0.98 for week 2; p = 0.5 
for week 3).  In other words, these weak positive trends in week 2 and week 3 probably 
don’t exist in the population that was sampled.  Statistically speaking, these trends are not 
significant. 
 The log odds of Candida growth declined with consumption of refined sugar 
during week 1 (Figure 2).  Slightly positive associations were observed in week 2 (b = 
0.005) and week 3 (b = 0.004).  However, the p-values associated with these slight 
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positive associations are quite large (p = 0.6 and p = 0.4), indicating that one cannot 
confidently conclude the trends exist in the overall population from which the 
participants were sampled. 
 
Association between Candida growth and consumption of other nutrients 
 The log odds of Candida growth were negatively associated with protein 
consumption all three weeks (Figure 3).  The associations were quite weak (b = – 0.04 
and smaller), and only week 1’s trend can be confidently viewed as likely existing in the 
population represented by the sample (p = 0.03). 
 The log odds of Candida growth among participants slightly decreased with total 
fat consumption during weeks 1 and 2 (Figure 4; b = − 0.05 and b = − 0.02, respectively).  
A very slight positive association was detected among week 3’s participants (Figure 4), 
but the trend probably doesn’t exist in the population represented by the sample (p = 0.9).  
 The log odds of Candida growth among participants decreased with saturated fat 
consumption during weeks 1 and 2 (Figure 5, b = −0.09 and b = − 0.01, respectively).  A 
negligible positive association was detected among participants during week 3 (Figure 5), 
however, week 3’s trend and week 2’s trend probably do not exist in the population 
represented by the sample (p = 0.9 and p = 0.5, respectively). 
 The log odds of Candida growth was negatively associated with %DV Vitamin A 
consumption for all three weeks (Figure 6).  The associations were negligible (Figure 6; b 
= −0.03, b = −0.02, and b = −0.005, respectively) and probably not true of the population 
being sampled (Figure 6; p = 0.1, p = 0.4, and p = 0.4, respectively). 
 There was very slight positive association observed between the log odds of 
Candida growth and consumption of vitamin C among study participants throughout 
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weeks 1, 2, or 3 of the study (Figure 7; b = 0.002, b = 0.005, and b = 0.002, respectively).  
These slight trends probably do not exist in the population represented by the sample 
(Figure 7; p = 0.3 or greater). 
 Results show a slight negative association between Ca consumption and the log 
odds of Candida growth among study participants during week 1 (Figure 8; b = – 0.01).  
However the magnitude of the associated p-value suggests this association is not true for 
the population (Figure 8; p = 0.2).  Slightly positive associations were detected in week 2 
(b = 0.007) and week 3 (b = 0.001).  However, these small trends detected in the sample 
probably are not indicative of trends in the population because the p-values related to the 
associations are very large (Figure 8; p = 0.6 and p = 0.9, respectively). 
 A weak negative association between the log odds of Candida growth and Fe 
intake was apparent during week 1, whereas a slight positive association was seen during 
week 2 (Figure 9; b = – 0.02, b = 0.01).  Practically no association was detected in week 
3 of the study (b = 0.001).  The associated p-values were too large to conclude that these 
trends exist in the sampled population (Figure 9; p = 0.2, p = 0.6, and p = 0.9, 
respectively). 
  
17 
 
 
 Figure 1.  Association between Candida growth and carbohydrate consumption.  
Observed growth of Candida (open circles) and estimated probability of Candida 
growth (dashed curve) as a function of mean daily carbohydrate consumption 
during three consecutive weeks of measurement.  Shaded area in each graph is the 
95% confidence interval associated with the estimated probability 
of Candida growth.  Regression coefficient is identified as “b.”  It expresses 
change in the log odds of Candida growth per 1g increase in carbohydrate 
consumption. 
  
b = – 0.02 
z = – 2.8 
p = 0.004 
b = 0.0001 
z = 0.02 
p = 0.98 
b = 0.002 
z = 0.75 
p = 0.5 
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 Figure 2.  Association between Candida growth and refined sugar consumption.  
Observed growth of Candida (open circles) and estimated probability of Candida 
growth (dashed curve) as a function of mean daily refined sugar consumption 
during three consecutive weeks of measurement.  Shaded area in each graph is the 
95% confidence interval associated with the estimated probability 
of Candida growth.  Regression coefficient is identified as “b.”  It expresses 
change in the log odds of Candida growth per 1g increase in refined sugar 
consumption. 
  
b = – 0.01 
z = – 1.8 
p = 0.08 
b = 0.005 
z = 0.6 
p = 0.6 
b = 0.004 
z = 0.9 
p = 0.4 
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 Figure 3.  Association between Candida growth and protein consumption.  Observed 
growth of Candida (open circles) and estimated probability of Candida growth 
(dashed curve) as a function of mean daily protein consumption during three 
consecutive weeks of measurement.  Shaded area in each graph is the 95% 
confidence interval associated with the estimated probability 
of Candida growth.  Regression coefficient is identified as “b.”  It expresses 
change in the log odds of Candida growth per 1g increase in protein consumption. 
  
b = – 0.04 
z = – 2.1 
p = 0.03 
b = – 0.02 
z = – 0.7 
p = 0.5 
b = – 0.002 
z = – 0.2 
p = 0.8 
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 Figure 4.  Association between Candida growth and total fat consumption.  Observed 
growth of Candida (open circles) and estimated probability of Candida growth 
(dashed curve) as a function of mean daily total fat consumption during three 
consecutive weeks of measurement.  Shaded area in each graph is the 95% 
confidence interval associated with the estimated probability 
of Candida growth.  Regression coefficient is identified as “b.”  It expresses 
change in the log odds of Candida growth per 1g increase in total fat 
consumption. 
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p = 0.01 
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 Figure 5. Association between Candida growth and saturated fat consumption.  
Observed growth of Candida (open circles) and estimated probability of Candida 
growth (dashed curve) as a function of mean daily saturated fat consumption 
during three consecutive weeks of measurement.  Shaded area in each graph is the 
95% confidence interval associated with the estimated probability 
of Candida growth.  Regression coefficient is identified as “b.”  It expresses 
change in the log odds of Candida growth per 1g increase in saturated fat 
consumption. 
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 Figure 6.  Association between Candida growth and %DV vitamin A consumption.  
Observed growth of Candida (open circles) and estimated probability of Candida 
growth (dashed curve) as a function of mean daily vitamin A consumption during 
three consecutive weeks of measurement.  Shaded area in each graph is the 95% 
confidence interval associated with the estimated probability of Candida growth.  
Three values have been omitted from the graphs (not the analyses) to better show 
the majority of observations.  Three values have been omitted from the graphs 
(not the analyses) to better show the majority of observations.  Week 1: (0, 
224).  Week 3: (0, 249) and (0, 294). 
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 Figure 7.  Association between Candida growth and %DV vitamin C consumption.  
Observed growth of Candida (open circles) and estimated probability of Candida 
growth (dashed curve) as a function of mean daily vitamin C consumption during 
three consecutive weeks of measurement.  Shaded area in each graph is the 95% 
confidence interval associated with the estimated probability of Candida growth.  
Two values have been omitted from the graphs (not the analyses) to better show 
the majority of observations.  Week 3: (0, 987) and (1, 1061). 
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b = 0.005 
z = 0.7 
p = 0.5 
b = 0.002 
z = 0.6 
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 Figure 8.  Association between Candida growth and calcium consumption.  Observed 
growth of Candida (open circles) and estimated probability of Candida growth 
(dashed curve) as a function of mean daily calcium consumption during three 
consecutive weeks of measurement.  Shaded area in each graph is the 95% 
confidence interval associated with the estimated probability of Candida growth.  
One value has been omitted from the graphs (not the analyses) to better show the 
majority of observations.   
Week 3: (0, 341). 
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 Figure 9.  Association between Candida growth and iron consumption.  Observed 
growth of Candida (open circles) and estimated probability of Candida growth 
(dashed curve) as a function of mean daily iron consumption during three 
consecutive weeks of measurement.  Shaded area in each graph is the 95% 
confidence interval associated with the estimated probability of Candida growth.  
Two values have been omitted from the graphs (not the analyses) to better show 
the majority of observations.  Week 1: (0, 207).  Week 3: (0, 142).  
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DISCUSSION 
 
 
 
 The goal of this study was to examine the rationale of the Candida cleanse diet 
(CCD) by testing if there is a positive association between carbohydrate intake and 
Candida growth as claimed by proponents of the diet.  The results of this study showed 
no positive association between the amount of carbohydrates an individual consumes and 
the presence of Candida in their mouths, suggesting the rationale behind the Candida 
cleanse diet is flawed.  A limited number of studies have reported varying and often 
conflicting results, providing little scientific evidence for the rationale of the CCD 
(Vargas et al. 1993, Russell and Jones 1973).  Conversely, there is an abundance of 
anecdotal evidence claiming the Candida cleanse diet  effective in spite of a lack of 
scientific evidence.  The discussion that follows will offer a possible alternative 
explanation for reported success of the CCD, namely that people on the diet tend to eat 
healthy foods that boost their immunity and maintain a healthy community of symbiotic 
microorganisms.  It will also examine the week-to-week variability in experimental 
participants with Candida growth.  Finally, the discussion that follows will offer some 
explanation for the differing frequencies of Candida congeners detected among the 
experiment’s participants. 
 
Could healthier food explain positive effects of Candida cleanse diets? 
 Regardless of whether Candida cleanse diets are effective, the rationale claimed 
by the diet’s proponents is apparently wrong.  Proponents claim the diet reduces 
Candida’s growth and abundance by depriving Candida of carbohydrates, refined sugar 
in particular.  Results of the experiment reported herein clearly refute that claim.  Perhaps 
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the diet is effective simply because people on the diet eat healthier food.  After all, 
reducing carbohydrates typically means reducing consumption of processed foods, many 
of which are rich in simple carbohydrates.  Eliminating processed foods from one’s diet 
leaves one eating whole foods.  Eating whole foods does not eliminate carbohydrates or 
even simple carbohydrates such as disaccharides and mono-saccharides from one’s diet, 
but the carbohydrates in whole fruits and whole vegetables are typically found in 
combination with lipids, proteins, and vitamins.  The balance of these nutrients likely 
improves immune function, which is likely the reason Candida cleanse diets are 
reportedly effective.  A healthy diet, as explained below, improves immune response and 
helps maintain an internal microbial community that is better able to competitively 
exclude pathogens such as Candida. 
 Foods containing refined ingredients are poor in micronutrients vital to proper 
immune development (Rowbotham 2008).  Proper nutrition containing a sufficient supply 
of micronutrients is responsible for numerous and varied immune mechanisms necessary 
to successfully combat invading pathogens (Calder and Jackson 2000).  The interaction 
of various micronutrients found in a diet of whole foods maintains immune cell activity 
such as ensuring proper phagocytic activity by macrophages (Calder and Jackson 2000).  
People on Candida cleanse diets probably get these micronutrients because they’re likely 
eating whole foods rather than processed foods. 
 A balanced diet includes a proper balance of all food groups including a variety of 
fruits and vegetables which contain phytochemicals.  Phytochemicals are chemical 
compounds found in fresh fruits and vegetables most processed foods lack.  These 
compounds (e.g., phenolics, carotenoids) act as antioxidants, reducing damage done by 
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reactive oxygen species (Esfahani et al. 2011).  Reactive oxygen species are produced 
during the course of infection to combat invading pathogens but can also cause damage to 
host tissue in large quantities (Nathan and Shiloh 2000).  Such tissue damage may allow 
Candida to penetrate the mucous membranes leading to systemic infection, therefore the 
antioxidant properties of phytochemicals play a vital role in a healthy immune system.  
CCD advocates claim penetration of organs underlying the intestinal mucosa may be 
responsible for many Candida associated symptoms (Truss 1981). 
 Rats administered antioxidant supplements and subsequently irradiated to induce 
intestinal tissue damage had less damage and healed more quickly than control rats not 
given the supplements (Anwar et al. 2013).  Also using a murine model researchers found 
that grape seed oil, a source rich in flavonoids, a ubiquitous polyphenol, is effective at 
protecting the mucosal lining of the gastrointestinal system from reactive oxygen species 
generated by stress (Manashi et al. 1999).  The antioxidants we get by eating fruits and 
vegetables may reduce tissue damage from oxidation, and thereby protect against 
Candida infection. 
 People with a diet rich in carotenoids, a type of phytochemical, are more resistant 
to infection and have a lower mortality than counterparts lacking adequate carotenoid 
consumption (Diplock et al. 1998).  Carotenoids are phytochemicals primarily assembled 
from catabolized fat molecules.  The carotenoid β carotene is a precursor to vitamin A 
meaning their consumption should lead to increased vitamin A thereby boosting the 
immune system and controlling Candida growth.   
 Erikson et al. (2007) has extensively reviewed the positive relationship between a 
diet containing the correct balance of vitamins including A, B6, B12, C, and D, with 
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healthy immune function.  For example, neutrophil development is modulated by vitamin 
A (Twining et al. 1997).  Furthermore, vitamin A shortage leads to a defect in 
neutrophils’ phagocytic capabilities despite their increased numbers in the bloodstream.  
This defect renders the immune cells relatively useless in the case of microbial invasion 
(Ongsakul et al. 1985).  Although this study found a consistent, weak negative 
association between vitamin A consumption and Candida growth other studies indicate 
vitamin A plays a substantial role in proper immune function. 
 Vitamin C also plays a role in immune function and thus our defense against 
pathogens such as Candida.  Studies have linked Vitamin C consumption to the 
production of T lymphocytes as well as their phagocytic capabilities (Jariwalla and 
Harakeh 1996, Hemila 1997).  Although my results show a slight positive association 
between vitamin C consumption and Candida growth during all three weeks of the study, 
the magnitude of the association does not show the strong positive trend suggested by the 
literature. 
 Experiments reviewed by Wichers (2009) show adequate protein intake is related 
to proper functioning of innate immunity in mice, particularly the activity of T-cells 
(Mainali and McMurray 1998).  However, restoring protein shortage is able to return 
immune function to usual levels (Wichers 2009).  Protein plays a variety of roles in 
protecting the body from Candida and oother invaders.  The mucous membrane lining of 
the intestinal tract is impaired by protein deprivation (Deitch et al. 1990) allowing for the 
dissemination of Candida throughout the body.  In addition protein malnutrition is 
associated with impaired lymphoid organs and decreased circulating lymphocytes 
(Woodward and Miller 1991).  Calprotectin, a protein found in the healthy immune cells 
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granulocytes, leukocytes, and macrophages, is effective against C. albicans as well as 
other Candida species (Müller et al. 1993, Sohlne et al.1991, Steinbakk et al. 1990) 
 Deficiency of minerals, including iron, calcium and zinc, are well documented to 
impair immune function in experimental animals, and to the extent studied, in humans as 
well (Keusch 2003).  Iron is important to the function of both the adaptive and innate 
immune mechanisms.  More specifically iron is required for the timely development of 
cytotoxic effector T lymphocytes (Santos and Falcao 1990).  Iron deficiency has been 
associated with impaired phagocytic activity toward fungi, including Candida (Higgs and 
Wells 1972).  Calcium is also involved in proper T-cell maturation.  Stimulation of T-cell 
receptors triggers massive Ca
2+
 influx into T-cells activating calcineurin, a phosphatase 
which activates the expression of genes involved in T-cell development (Crabtree and 
Olson 2002).  The negligible associations between Candida growth and both iron and 
calcium may indicate that consumption of these minerals by most participants exceeded 
the minimum required by Candida.  
 A possible connection among nutrition, inflammation, and symptoms reportedly 
treated by CCD suggests that alleviation of symptoms by Candida cleanse diets is merely 
the result of a better functioning immune system associated, not with reduced 
carbohydrate, per se, but instead with simply eating healthier foods that enable the body 
to better maintain a healthy balance of intestinal microbes. 
 
Week-to-week variability 
 Most associations between Candida growth and each nutrient varied slightly from 
week to week (Figures 1-9).  Some nutrients shifted from a positive to negative 
association or the reverse, changing from week to week, whereas others maintained a 
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consistent positive or negative association.  Responses for both carbohydrates and refined 
sugars varied in a similar manner, which makes sense because refined sugars are 
carbohydrates.  Both had a strong negative association with Candida growth during the 
first week, and both had a slight positive association with Candida growth in weeks 2 and 
3 (Figures 1 and 2).  Likewise, trends in total fat were similar to those for saturated fat.  
Both had negative associations with Candida growth during weeks 1 and 2 and slight 
positive associations with Candida growth during week 3 (Figures 4 and 5).  Protein, 
vitamin A, and vitamin C were the only measured nutrients for which results were 
consistent week to week.  Protein had a relatively strong negative association with 
Candida growth during week 1.  The negative trend was small in week 2 and negligible 
in week 3 for the study’s participants.  Vitamin A consumption was consistently 
negatively associated with growth of Candida (Figure 6).  Although the result is valid 
only for the observed samples and probably not the populations from which they were 
drawn, this trend makes sense because vitamin A is associated with immune function.  In 
contrast, vitamin C intake was positively associated with Candida growth for the duration 
of the study (Figure 7).  These results for vitamin A and vitamin C suggest that vitamin A 
might play a marginal role in controlling Candida growth in the study’s participants, 
whereas vitamin C might slightly facilitate Candida growth in the study’s participants.  
Both Ca and Fe were negatively associated with Candida growth during week 1, but both 
were slightly positively associated with growth during weeks 2 and 3 (Figures 8 and 9). 
 One explanation for these week-to-week discrepancies may be that participants 
maintained more accurate dietary records as the study progressed.  Perhaps week 1’s 
results are anomalies associated with participants learning to keep track of their diets.  
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Participants initially failed to consider all ingredients in foods that contained many 
ingredients.  Participants also had to learn how to judge the amount of each food item 
they ate.  Consequently, accuracy probably increased from week to week.  It is also 
possible that participants became better at sampling their mouths and inoculating 
CHROMagar plates. 
 
Conclusion 
 The results of this study suggest the rationale of Candida cleanse diets is flawed.  
CCD advocates claim that a range of physical and mental ailments can be cured by 
eliminating Candida from one’s system, and they claim elimination of Candida can be 
accomplished by reducing carbohydrate consumption, particularly the elimination of 
refined sugars from one’s diet.  This rationale predicts a positive association between the 
growth of Candida and the amount of carbohydrate consumed.  However, consumption 
of carbohydrates, including refined sugar, appear to have either a negative association or 
no association with growth of Candida.  Only a strongly negative association and 
negligibly weak positive associations were detected in this study. 
 Studies addressing the effect of these nutrients on Candida growth are sparse.  
However, many personal accounts of symptom improvement exist, suggesting Candida 
cleanse diets effectively reduce growth of Candida.  These anecdotal reports of CCD 
efficacy apparently reflect an effect unrelated to carbohydrate restriction.  Reported 
improvements are possibly a consequence of better immune function caused by the 
consumption of a healthier diet, particularly one higher in vegetables and unprocessed 
foods.  Such a diet provides the essential vitamins, phytochemicals, and minerals that are 
often lacking in an unbalance diet.  All of these factors have been shown to contribute to 
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a fully functional immune system.  These observations lead to the conclusion that 
although the rationale underlying Candida cleanse diets is flawed, the diet may be 
effective simply because people on the diet likely become more conscientious about their 
food, reduce their consumption of processed foods, and consequently eat healthier foods 
that strengthen their immune systems and help maintain a balanced microbial community 
that can competitively exclude Candida. 
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APPENDICES 
 
 
 
Appendix 1.  These websites were used to determine the nutritional value of a 
variety of items, especially those not available from manufacturer website or 
ingredients used in homemade meals.  The remaining sites were used for more 
than one variety or type of item. 
 
http://www.caloriecount.about.com 
http://www.nutritiondata.self.com 
http://www.fatsecret.com 
http://www.enutrition.sysco.com 
http://www.sparkpeople.com 
http://www.myfitnesspal.com/nutrition-facts-calories 
http://www.pepsico.com 
http://www.productnutrition.thecoca-colacompany.com 
http://www.drpepper.com/text/products/drpepper/nutrition 
http://www.chick-fil-a.com/food/meal 
http://www.mcdonalds.com/us/en/food/food_quality/nutrition_choices.html 
https://pandaexpress.com/NutritionCalculator 
http://www.subway.com/nutrition/nutritionlist.aspx 
http://www.bk.com/en/us/menu-nutrition/index.html 
http://order.papajohns.com/nutrition.html 
http://www.tacobell.com/nutrition 
http://arbys.com/build-a-meal 
http://www.ryans.com/menus/nutritional-information 
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Appendix 1 (cont.) 
https://order.dominos.com/en/pages/content/nutritional/nutrition.jsp 
http://www.applebees.com/~/media/docs/Applebees_Nutritional_Info.pdf 
http://www.zaxbys.com/menu_nutrition/nutritional_information.aspx 
http://www.einsteinbros.com/nutrition/calculator 
http://www.starbucks.com/menu/nutrition 
http://www.javacity.com/beverages_nutritionals.php 
http://www.freshens.com 
http://www.smoothieking.com/smoothies/nutritional-chart.php 
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Appendix 2.  A selection of sources describing Candida cleanse diets. 
 
Websites describing Candida cleanse diets 
http://naturalcandidacleansing.com 
http://www.thecandidadiet.com 
http://www.doctoroz.com/blog/jacob-teitelbaum-md/candida-eliminating-yeastfungal 
overgrowth 
http://www.everydiet.org/diet/candida-diet 
http://www.candidaplan.com/new/the_plan (Dr. Jeff McCombs) 
http://www.naturalcandidacleansing.com/candidadietgoodfoods.html 
http://www.everydiet.org/diet/candida-diet (Mizpah Matus B.Hlth.Sc) 
http://www.bodyecology.com 
http://www.how-to-boost-your-immune-system.com/candida-diet-and-colon-cleansing 
http://www.raysahelian.com/candida 
http://www.candidacleanser.com 
http://www.candida-cure-recipes.com 
http://www.candidasupport.org 
http://www.guidetobodycleansing.com/candidacleansingdiet 
http://www.wholeapproach.com/diet 
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Appendix 2 (cont.) 
Books describing Candida cleanse diets 
Boehner, Sandra. The Candida Diet Solution. Kindle Ed. 73 pg. 2014. 
Boroch, Ann. The Candida Cure: Yeast, Fungus & Your Health - The 90-Day Program to 
Beat Candida & Restore Vibrant Health. DeVecchi, Paul. The Candida Cleanse 
Solution: How To Cure Candida Naturally in 21 days.  
Weil, Christine. Candida Cleanse: Cure Candida & Restore Your Health Naturally in 21 
Days: Natural Health & Natural Cures Series.  
Reese, Michael E. The Candida Cleanse Diet: How To Cure Candida 12 Weeks with a 
Natural Candida Diet. 
Jackson, Natalie. The Candida Cure: A Simple Candida Cleanse Program to Help 
Restore Your Health Naturally in 14 Days.  
Jackson, Natalie. The Candida Cure: A Simple, Easy to Follow 5 Step Candida Diet 
Solution Guide.  
Kaufman, Joseph. Candida Diet Cleanse Program: The Complete Candida Cure Guide 
for Conquering Candida Albicans! 
Kelleher, Saira. Candida Cure Solution - The Ultimate Candida Diet & Cleanse Guide 
For Overcoming Candida.  
Michaels, Jennifer. Candida Cure: Beat Candida (Yeast Infection) For Life: How a 
Natural Candida Cleanse Diet Can Cure Candida.  
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Appendix 2 (cont.) 
Supplements recommended by Candida cleanse diets 
10 Day Candida Cleanse. (Dherbs)  
Candida Cleanse. (CandidaPro) 
Candida Cleanse and Digestion Formula102. (Kyolic) 
Candida Cleanse - 7 Day Program Kit. (Nature's Plus) 
Candida Cleanse Complex - All-in-One Yeast Infection Treatment. (Candida Cleanse 
Complex) 
Candida Support Complex. (Vitaana Health) 
Candida Quick Cleanse. (Zand)  
Candistroy. (Nature's Secret) 
Now Foods Candida Support Formula (Now Foods) 
Original Parasite Cleanse and Candida Cleanse Kit. (OneLifeUSA) 
Renew Life CandiGONE (Renew Life).  Ultimate Candida Cleanse Complex. (Natural 
Goal) 
Yeast Cleanse. (Solaray) 
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Appendix 3.  Dietary record of one of the 116 participants. 
 
 
